Medikamentöse und nicht-medikamentöse Versorgung von Menschen mit schwerer Demenz in Pflegeheimen
Year: 2023
Type: dissertation
Abstract: Background and aims More than one third of the residents of German nursing homes live with severe dementia. This stage of the disease is associated with very severe cognitive impairments, limitations in daily living skills and behavioural changes, which always constitute great challenges for caregivers. The symptoms of dementia can be treated either pharmacologically or non-pharmacologically, whereby behavioural symptoms should always be treated non-pharmacologically first. There are numerous non-pharmacological therapy approaches for people with mild to moderate dementia, but there is a lack of evaluated concepts for people with severe dementia. People with dementia of all degrees of severity are often treated with psychotropic drugs, but there is hardly any data about this for people with severe dementia. The aim of this dissertation is therefore, to analyse the prescription rates of psychotropic drugs for people with severe dementia and to introduce the study protocol of a multi-component intervention for people with severe dementia (MAKS-s). Methods The MAKS-s study was conducted as a two-arm, cluster-randomised study in a waiting list control group design. For this purpose, 26 nursing homes with a total of 144 participants from different German states were to be recruited. The quality of life, the psychological and behavioural symptoms and the everyday practical skills of the participating people with severe dementia were assessed before the start, after two months and after six months. The nursing homes of the intervention group were trained in the implementation of the MAKS-s intervention before the start of the study. The intervention consists of the four components social, motor, cognitive and everyday practical skills training and was carried out three times a week, for one hour each. The baseline data of the study participants, who could not be used for the randomised controlled trial due to the Covid-19 pandemic, were cross-sectionally analysed regarding their psychotropic drug prescriptions. Results Three quarters of the sample received at least one psychotropic drug, the most common being antipsychotics (56 %). Antidepressants were given to 26%, antidementia drugs to 20% and tranquillisers and hypnotics to 8% of the sample. 80% of the participants showed clinically relevant neuropsychiatric symptoms, with aberant motor behaviour (36%) being the most common. When the control variables were included, it was found that both older people (OR = 0.908; 95% CI [0.849; 0.972], p = 0.005) and people with more physical comorbidities (OR = 0.804; 95% CI [0.645; 1.004], p = 0.054) were less likely to be prescribed an antipsychotic. People with more physical comorbidities were also significantly less likely to be prescribed antidementia drugs (OR = 0.629; 98% CI [0.415; 0.946], p = 0.026). Women had a significantly lower chance of being prescribed antidementia drugs than men (OR = 0.160; 95% CI [0.066; 0.565], p = 0.003). The results of the randomised controlled trial are not the subject of this dissertation. Discussion Although the use of psychotropic drugs and especially antipsychotics in people with dementia is always heavily criticised, our study one more time showed that a majority of the people with severe dementia in the nursing homes were treated with at least one antipsychotic drug. It is striking that in the present study, on the one hand, there is a high prescription rate of psychotropic drugs (74 %), but on the other hand, at the same time, there is a high prevalence of clinically relevant NPS (80 %). The indication of psychotropic drugs and antipsychotics in particular should be provided more critically and non-pharmacological therapies should be used more often, as recommended by various guidelines. The multi-component intervention MAKS-s offers a possible alternative here.
Author: Diehl, Kristina
Institution: Friedrich-Alexander-Universität Erlangen-Nürnberg
Language: German
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7020949561
